Podcast/ R&D/ Views & Analysis/ Views and analysis GSK and eosinophil research: the pharmaphorum podcast Dominic Tyer eosinophil, GSK, podcast 0 Comment GlaxoSmithKline’s Nucala (mepolizumab) last month became the first and only biologic treatment approved in the US for Hypereosinophilic Share X GSK and eosinophil research: the pharmaphorum podcast https://pharmaphorum.com/r-d/gsk-eosinophil-research-podcast/
